Since March, when the Covid-19 crisis started, hearing firm Demant has undergone a significant transitional process, where almost all work procedures in the C25 company have been subjected to a 'new normal' with virtual work processes becoming standard rather than physical meetings and face-to-face interactions.
Demant's recent transition leads the President and CEO Søren Nielsen to strongly believe that the firm's new flagship product, the hearing aid Oticon More, will be successful. It replaces its predecessor, the blockbuster Oticon Opn S.
Get full access for you and your coworkers.Start a free company trial today
Already a member? Log in.